Latest edition of the Journal of Neuromuscular Diseases now online – Jun 2020
Published: 08 June 2020
A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below:
Journal of Neuromuscular Diseases: Volume 7, issue 3
(click to view it at the journal website)
*Hanns is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.
Articles in this issue:
- Is gene size an issue for the diagnosis of skeletal muscle disorders?
- Clinical phenotypes of DMD exon 51 skip equivalent deletions: A systematic review
- Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy
- Evaluation of genotypes and epidemiology of spinal muscular atrophy in Greece: A nationwide study spanning 24 years
- Prospective cohort study of nusinersen treatment in adults with spinal muscular atrophy
- Retrospective analysis of exulizumab in partients with acetylcholine receptor antibody-negative myasthenia gravis: A case series
- Laboratory tests for neuropathies: What to do and to avoid
- Dysphagia and dysarthria in children with neuromuscular diseases, a prevalance study
- Myasthenia gravis impairment index: Sensitivity for change in generalized muscle weakness
- Confirmation of TAC01 as a Leigh syndrome disease gene in two additional families
- Carey-Fineman-Ziter syndrome: A MYMK-related myopathy mimicking brainstem dysgensis
- Blood flow to the spleen is altered in a mouse model of spinal muscular atrophy
- Feeding and swallowing problems in infants with spinal muscular atrophy type 1: An observational study
- Assessing physical activity using accelerometers in youth with Duchenne muscular dystrophy
- Rehabilitation following fracture in dystrophinopathy, a case series
- Chronic progressive external ophthalmoplegia due to a rare de novo m.12334G>A MT-TL2 mitochondrial DNA variant
- COVID-19 in refractory myasthenia gravis – A case report of successful outcome
- Myotubular trust – 2020 call for projects (open to international applications)
Read next...
Two Research Lab Members Receive CIHR Funding Awards!
We are excited to share that two of our research team members have received competitive funding awards from the Canadian Institutes of Health Research (CIHR)...
Dr. Hanns Lochmüller’s Canada Research Chair Renewed Through 2032
We are pleased to announce that Dr. Hanns Lochmüller’s Tier 1 Canada Research Chair (CRC) in Neuromuscular Genomics and Health has been renewed through the...
Dr. Kiran Polavarapu Appointed Scientist at the CHEO Research Institute
We are delighted to congratulate Dr. Kiran Polavarapu on his appointment as Scientist at the Children’s Hospital of Eastern Ontario Research Institute (CHEO RI). This...
Meet The Lab’s New Clinical Members!
Our research team is growing! We are excited to announce three new research staff who have joined the lab this winter, as well as two...
Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine
We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice
Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...